Mohammed S. Aldughaim
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 4
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Peptidase Inhibition and Analysis 2
-
- Natural Antidiabetic Agents Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Azeez YusufHanan A. HenidiAwatif Rashed Z. AlmotairyOhoud Y. AlshehriMohsin KaziFars K. AlanaziXingping QinMuhammad Delwar Hussain
- Journals
- PLoS ONE (1 paper)Molecules (5 papers)Environmental Science and Pollution Research (1 paper)
- Partner nations
- Saudi ArabiaUnited StatesUnited Kingdom
In The Last Decade
Mohammed S. Aldughaim
25 papers receiving 710 citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Pharmaceutical Science 111
- Biomaterials 189
- Molecular Medicine 29
- Developmental Neuroscience 20
- Biomedical Engineering 171
Countries citing papers authored by Mohammed S. Aldughaim
This map shows the geographic impact of Mohammed S. Aldughaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed S. Aldughaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed S. Aldughaim more than expected).
Fields of papers citing papers by Mohammed S. Aldughaim
This network shows the impact of papers produced by Mohammed S. Aldughaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed S. Aldughaim. The network helps show where Mohammed S. Aldughaim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed S. Aldughaim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 28 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 19 | |
| 18 | 2020 | 4 | |
| 19 | 2020 | 1 | |
| 20 | 2019 | 76 |
About Mohammed S. Aldughaim
Mohammed S. Aldughaim is a scholar working on Pharmaceutical Science, Biomaterials and Neurology, having authored 27 papers that have together received 728 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (5 papers), COVID-19 Clinical Research Studies (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Peptidase Inhibition and Analysis (2 papers), Natural Antidiabetic Agents Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pharmaceutical Science (111 citations), Biomaterials (189 citations) and Molecular Medicine (29 citations). Mohammed S. Aldughaim has collaborated with scholars based in Saudi Arabia, United States and United Kingdom. Frequent co-authors include Azeez Yusuf, Hanan A. Henidi, Awatif Rashed Z. Almotairy, Ohoud Y. Alshehri, Mohsin Kazi, Fars K. Alanazi, Xingping Qin, Muhammad Delwar Hussain, Yi Zhong and Qiurong Xie. Their work appears in journals such as PLoS ONE, Molecules and Environmental Science and Pollution Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.